Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Up 114.4% in March
Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Up 114.4% in March
Entera Bio Ltd. (NASDAQ:ENTX – Get Rating) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 185,900 shares, a growth of 114.4% from the February 28th total of 86,700 shares. Based on an average daily trading volume, of 229,000 shares, the days-to-cover ratio is presently 0.8 days. Approximately 0.8% of the shares of the company are sold short.
企業生物有限公司（NASDAQ：ENTX-獲取評級）在三月份，短期利益增長的接收者。截至 3 月 15 日，總共有 185,900 股股份的短期利息，較 2 月 28 日的總共 86,700 股股份增長了 114.4%。根據平均每日交易量 229,000 股，日數佔覆蓋率目前為 0.8 天。該公司約 0.8％ 的股份賣空。
Entera Bio Trading Up 3.3 %
企業生物交易上升 3.3%
NASDAQ:ENTX traded up $0.03 during mid-day trading on Tuesday, reaching $1.06. 30,055 shares of the stock were exchanged, compared to its average volume of 240,150. The company has a 50 day simple moving average of $0.99 and a 200-day simple moving average of $0.89. Entera Bio has a 1 year low of $0.47 and a 1 year high of $3.00.
納斯達克：ENTX 在周二中間交易期間上漲了 0.03 美元，達到 1.06 美元。與其平均交易量為 240,150 股相比，該股票的交易量為 30,055 股。該公司擁有 50 天的簡單移動平均線 0.99 美元，以及 200 天的簡單移動平均線為 0.89 美元。企業生物有 1 年的低點 0.47 美元和 1 年的高點 3.00 美元。
Institutional Inflows and Outflows
機構流入和流出
Hedge funds have recently added to or reduced their stakes in the company. Renaissance Technologies LLC grew its holdings in Entera Bio by 555.4% during the fourth quarter. Renaissance Technologies LLC now owns 139,600 shares of the company's stock worth $102,000 after acquiring an additional 118,300 shares during the period. Millennium Management LLC increased its stake in Entera Bio by 358.5% during the fourth quarter. Millennium Management LLC now owns 46,000 shares of the company's stock worth $34,000 after acquiring an additional 35,968 shares during the last quarter. Finally, PNC Financial Services Group Inc. acquired a new stake in Entera Bio during the first quarter worth about $29,000. Hedge funds and other institutional investors own 20.12% of the company's stock.
對沖基金最近增加或減少了他們在公司的股份。文藝復興技術有限責任公司在第四季度增長了在 Entera 生物的控股 555.4%.在此期間，文藝復興科技有限責任公司現在擁有該公司股票的 139,600 股價值 102,000 美元。千年管理有限責任公司在第四季度增加了其在 Entera 生物的股份 358.5％。千禧管理有限責任公司現在擁有該公司股票的 46,000 股，價值 34,000 美元，在上個季度額外收購 35,968 股後。最後，PNC 金融服務集團股份有限公司在第一季度收購了 Entera Bio 的新股份，價值約為 29,000 美元。對沖基金和其他機構投資者擁有公司股票的 20.12%。
About Entera Bio
關於企業生物
(Get Rating)
(取得評分)
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH, GLP-E, and hGh, The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
Entera Bio Ltd. 是一家臨床階段的生物製藥公司，從事口服大分子治療藥物的開發和商業化。它的管道包括 PTH, GLP-E, 和生長激素, 該公司成立于九月 30, 2009 總部設在耶路撒冷, 以色列.
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on Entera Bio (ENTX)
- Meta Breaks Out Of A Base, Looks Like A Growth Stock Again
- Here's Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
- The Bottom Is In For McCormick & Company
- Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
- Roku And The 20% Rally That's About To Start
- 獲取有關企業生物研究報告的免費副本
- Meta 突破了基礎，看起來再次成長股
- 這就是為什麼維京療法在肥胖症藥物數據上漲了 50％ 以上的原因
- 底部是在麥考密克 & 公司
- 沃爾格林靴子聯盟：藍籌，高收益周轉故事
- Roku 和即將開始的 20％ 拉力賽
Receive News & Ratings for Entera Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entera Bio and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Entera 生物日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Entera Bio 及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。